Related content

High serum levels of YKL‐40 in patients with systemic sclerosis are associated with pulmonary involvement

By Nordenbæk C.   Johansen J. S.   Halberg P.   Wiik A.   Garbarsch C.   Ullman S.   Price P. A.   Jacobsen S.  

Scandinavian Journal of Rheumatology, Vol. 34, Iss. 4, 2005-08 ,pp. : 293-297

Informa Healthcare

Access to resources Recommend Favorite

The levels of serum-soluble Fas in patients with rheumatoid arthritis and systemic sclerosis

By Ateş Aşkın   Kinikli Gülay   Turgay Murat   Duman Murat  

Clinical Rheumatology, Vol. 23, Iss. 5, 2004-10 ,pp. : 421-425

Springer Publishing Company

Access to resources Recommend Favorite

Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis

By Hasegawa Minoru   Fujimoto Manabu   Matsushita Takashi   Hamaguchi Yasuhito   Takehara Kazuhiko   Sato Shinichi  

Clinical Rheumatology, Vol. 30, Iss. 2, 2011-02 ,pp. : 231-237

Springer Publishing Company

Access to resources Recommend Favorite

Pulmonary functional abnormalities in asymptomatic patients with systemic sclerosis

By Marcisz C.   Kucharz E.J.   Brzezinska-Wcislo L.   Kotulska A.   Jonderko G.  

European Journal of Internal Medicine, Vol. 14, Iss. 3, 2003-05 ,pp. : 162-165

Elsevier

Access to resources Recommend Favorite

A Decreased Serum Leptin Level in Patients with Systemic Sclerosis

By Kotulska A.   Kucharz E. J.   Brzezińska-Wcisło L.   Wadas U.  

Clinical Rheumatology, Vol. 20, Iss. 4, 2001-07 ,pp. : 300-302

Springer Publishing Company

Access to resources Recommend Favorite